11 In our study, the changes associated with MVP, in comparison with control DDDR arm, did not reach statistical significance either for the primary endpoint or for long-duration AF and for permanent AF (the latter despite an increased use of cardioversion).
← all excerpts
Atrial antitachycardia pacing and managed ventricular pacing in bradycardia patients with paroxysmal or persistent atrial tachyarrhythmias: the MINERVA randomized multicentre international trial.
1
—
—